Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00295932
Status:
COMPLETED
Last Update Posted:
2018-11-20
First Post:
2006-02-23
Brief Title:
Bortezomib Rituximab Cyclophosphamide and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkins Lymphoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
| Leukemia |
Keywords:
| Name | View |
|---|---|
| splenic marginal zone lymphoma | View |
| recurrent grade 1 follicular lymphoma | View |
| recurrent grade 2 follicular lymphoma | View |
| recurrent grade 3 follicular lymphoma | View |
| recurrent small lymphocytic lymphoma | View |
| recurrent marginal zone lymphoma | View |
| Waldenstrom macroglobulinemia | View |
| recurrent mantle cell lymphoma | View |
| refractory chronic lymphocytic leukemia | View |
| B-cell chronic lymphocytic leukemia | View |
| extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue | View |
| nodal marginal zone B-cell lymphoma | View |